- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06140979
Visual Focused Play Intervention for Children With ADHD
November 18, 2023 updated by: Xijing Hospital
Efficacy of Visual Focusing Game on Children With Attention Deficit Hyperactivity Disorder and Mechanisms of Functional Near-Infrared Spectroscopic Imaging
This is a single-center, randomized, double-blind, sham-controlled study that will recruit children with attention deficit hyperactivity disorder and randomly assign them to a test group and a control group.
The patients in the test group will be given a visual focus game to play and the patients in the control group will be given an animated video of the game that had no therapeutic effect.
Treatment will be required at least 5 times per week for 2 weeks, with each game or video session lasting 30 minutes.
Clinical scales and functional near-infrared spectroscopic imaging will be performed before and at the end of the 2 weeks of treatment, respectively.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Min Cai
- Phone Number: 86-15353508787
- Email: mincai8787@hotmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Meeting the diagnostic criteria for ADHD in the U.S. Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5);
- Aged 6-14 years old;
- Right-handedness (habitual or good use of the right hand in daily life, work, study and labor activities);
- Voluntarily agree to sign an informed consent form;
Exclusion Criteria:
- Wechsler Intelligence Scale for Children (WISC) <80 points;
- The cranial CT or MRI found that there are clear infarction foci, soft foci, occupations and other organic lesions;
- Suffering from serious physical diseases or other severe mental diseases, such as schizophrenia, bipolar disorder, etc;
- Inability to cooperate with fNIRS data collection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Test Group
The patients in the test group will be given a visual focus game to play, and the treatment will be required at least 5 times per week for 2 weeks, with each session lasting 30 minutes.
|
The intervention is based on a parkour game in which the player runs forward as a cartoon character, avoiding obstacles in front of him/her while collecting gold coins and various props.
In this process, players need to stay focused and operate in time to avoid obstacles or collect rewards, and as time goes on, the difficulty of the game increases until eventually they cannot avoid obstacles.
As time goes on, the difficulty of the game will increase until the end of the game when you can't avoid the obstacles.
|
|
Sham Comparator: Control Group
The patients in the control group were given an animated video of the game that had no therapeutic effect, and the video will be required at least 5 times per week for 2 weeks, with each session lasting 30 minutes.
|
The intervention consists of a 30-minute non-therapeutic video of a parkour game, which is paused every 10 minutes and requires the patient to click "continue" until the end of the video.
No other action is required.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Attention Deficit Hyperactivity Disorder Rating Scale scores between baseline and post-treatment
Time Frame: Baseline and 2 weeks
|
The Attention Deficit Hyperactivity Disorder Rating Scale is commonly used to determine whether children have symptoms of ADHD, how severe they are, and how impaired they are.
As such, it is a combination of symptom and functional impairment ratings (e.g., unless it is at least moderately impaired to rate a 2 or 3 on a symptom).
This is usually done by the clinician based on information provided by the parent/guardian or teacher.
|
Baseline and 2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the Parent Symptom Questionnaire scores between baseline and post-treatment
Time Frame: Baseline and 2 weeks
|
The Parent Symptom Questionnaire is a child behavior rating scale for parents developed by Conners that is easy to understand and takes parents only 5 to 10 minutes to complete.
The scale is primarily used to assess attention deficit hyperactivity disorder in children and can reflect the effectiveness of treatment.
|
Baseline and 2 weeks
|
|
Changes in Functional Near-Infrared Spectral Imaging between Baseline and Post-Treatment
Time Frame: Baseline and 2 weeks
|
Functional near-infrared spectroscopic imaging is a safe and fast screening method.
It reflects brain activity by measuring blood oxygen levels in the cerebral cortex with promptness, accuracy, and short duration.
|
Baseline and 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Min Cai, The First Affiliated Hospital of the Air Force Medical University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Anguera JA, Boccanfuso J, Rintoul JL, Al-Hashimi O, Faraji F, Janowich J, Kong E, Larraburo Y, Rolle C, Johnston E, Gazzaley A. Video game training enhances cognitive control in older adults. Nature. 2013 Sep 5;501(7465):97-101. doi: 10.1038/nature12486.
- Barkley RA. Attention-deficit/hyperactivity disorder, self-regulation, and time: toward a more comprehensive theory. J Dev Behav Pediatr. 1997 Aug;18(4):271-9.
- Pandian GSB, Jain A, Raza Q, Sahu KK. Digital health interventions (DHI) for the treatment of attention deficit hyperactivity disorder (ADHD) in children - a comparative review of literature among various treatment and DHI. Psychiatry Res. 2021 Mar;297:113742. doi: 10.1016/j.psychres.2021.113742. Epub 2021 Jan 19.
- Kollins SH, Childress A, Heusser AC, Lutz J. Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD. NPJ Digit Med. 2021 Mar 26;4(1):58. doi: 10.1038/s41746-021-00429-0.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
November 10, 2023
Primary Completion (Estimated)
June 30, 2024
Study Completion (Estimated)
June 30, 2024
Study Registration Dates
First Submitted
November 12, 2023
First Submitted That Met QC Criteria
November 18, 2023
First Posted (Estimated)
November 21, 2023
Study Record Updates
Last Update Posted (Estimated)
November 21, 2023
Last Update Submitted That Met QC Criteria
November 18, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KY20232300-F-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity DisorderUnited States
Clinical Trials on Playing the game
-
University of IoanninaDOTSOFT SA - GR; TELEGLOBAL LP - GR; Region of Epirus (Regional Operational Programme... and other collaboratorsCompletedDevelopmental Articulation Disorder | Developmental Language Disorders | Speech Disorder | Neurodevelopmental Disorder (Diagnosis)Greece
-
Yadigar OrduGazi UniversityCompleted
-
Mayo ClinicCompletedCrohn's Disease | Ulcerative Colitis | Inflammatory Bowel DiseaseUnited States
-
Holland Bloorview Kids Rehabilitation HospitalCompleted
-
University of Southern CaliforniaSoar Technology; Creative Media and Behavioral Health Center; USC Center for...CompletedCommunicationUnited States
-
Mersin UniversityCompletedFear of Pain | Procedural PainTurkey (Türkiye)
-
Center for Social Innovation, MassachusettsResearch Foundation for Mental Hygiene, Inc.CompletedSchizophrenia | Schizoaffective Disorder | PsychosisUnited States
-
Ryerson UniversityDanone Institute International; Mount Saint Vincent UniversityCompleted
-
Mersin UniversityCompletedPain, Acute | Anxiety and FearTurkey
-
Dr. Sharon HassinTel Aviv University; Sheba Medical Center; Bar-Ilan University, IsraelUnknown